Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells

Written By Lara Wilson

Chen H. et al. 2020. Journal for ImmunoTherapy of Cancer. 8(2):e000515.

Lara Wilson
Previous

Antagonist antibodies targeting LAIR1 promote inflammatory phenotype in myeloid cells and activate lymphocytes
Next

Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4)